Reijneveld JC, Machingura A, Coens C, Taphoorn MJB, et al. Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Trea Eur J Cancer 2023;190:112946.
PMID: 37453240